Cancers Many anti-cancer substances have been shown to cause paraptosis in a large range of human cancer cells. This includes several compounds derived from natural sources Paraptosis is also an area of interest for Cancer Research as a way to treat apoptosis resistant cancers.
Paclitaxel, commonly distributed under the trade name Taxol, is a cancer drug used for the treatment of breast and ovarian cancers. At high concentrations (70 μM), one study showed it to induce a paraptosis-like cell death, and could be an important mechanism for treating apoptosis-resistant cancers. Steamed
American ginseng extract has been reported to "potently kill colorectal cancer cells". Specifically, derivatives of
protopanaxadiol Rg3 and Rh2, are the key ginsenosides found in the extract.
Honokiol, a compound derived from
Magnolia officinalis, can induce paraptosis in human
leukemia cells. In the NB4 cell line, paraptosis was the primary method of cell death. In
K562 cells, apoptosis was the primary mechanism, with paraptosis occasionally found. Another copper complex, the A0 thioxotriazole copper (II) complex, also caused paraptosis in HT1080
fibrosarcoma cells via endoplasmic reticulum stress and cytoplasmic vacuolization. Along with
cytotoxic effects such as an increase in oxidized
glutathione and prevention of
proteasome activity, A0 prevented the activity of caspase-3, which may inhibit apoptosis and cause the cells to die via paraptosis. IGF-1R is an important area of research for neurodegenerative diseases, as defects in IGF-1R signaling, including increased levels of IGF-1R, have been found in the brains of
Alzheimer's patients. ==Other examples==